2014
DOI: 10.1016/j.coph.2014.05.008
|View full text |Cite
|
Sign up to set email alerts
|

NSAID-gastroenteropathy: new aspects of pathogenesis and prevention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
61
0
7

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(69 citation statements)
references
References 33 publications
1
61
0
7
Order By: Relevance
“…However, the use of these medicines is frequently related with disorders on gastric mucosa, as well as on the renal and cardiovascular systems (Harirforoosh et al 2013). Non-steroidal anti-inflammatory drugs are also an important group of drugs largely utilized in the treatment of inflammatory diseases, acting by inhibition of the cyclooxygenase and then prevent the conversion of arachidonic acid to prostaglandins (Blackler et al 2014). Nevertheless, these drugs have some limitations and cannot regulate the production of leukotrienes or PAF that continues to cause inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…However, the use of these medicines is frequently related with disorders on gastric mucosa, as well as on the renal and cardiovascular systems (Harirforoosh et al 2013). Non-steroidal anti-inflammatory drugs are also an important group of drugs largely utilized in the treatment of inflammatory diseases, acting by inhibition of the cyclooxygenase and then prevent the conversion of arachidonic acid to prostaglandins (Blackler et al 2014). Nevertheless, these drugs have some limitations and cannot regulate the production of leukotrienes or PAF that continues to cause inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…In 2011, we reported that in rodents, suppression of acid secretion with PPIs, although effective at preventing gastroduodenal damage, resulted in a dramatic worsening of distal intestinal damage [13]. This was confirmed by others, and was shown to occur also with histamine H 2 receptor antagonists [14][15][16]. Moreover, there is clinical evidence linking use of PPIs and H 2 receptor antagonists to severe intestinal damage observed in rheumatoid arthritis patients taking NSAIDs [8].…”
mentioning
confidence: 53%
“…Roth, употреб-ляют для обозначения патологии желудка и две-надцатиперстной кишки, связанной с приемом НПВП и диагностируемой при наличии поврежде-ния слизистой оболочки гастродуоденальной зоны с формированием эрозий и язв, а также их ослож-нений (кровотечения, перфорация, нарушение про-ходимости и др.). Согласно действующей на се-годня Международной классификации болезней 10-го пересмотра (1993) эти осложнения обознача-ются «НПВП-гастропатия: язва желудка, осложнен-ная кровотечением» или другие эрозивно-язвенные поражения гастродуоденальной зоны (Y 45.8, K 25, K 92) [15,18,23,41,47].…”
Section: Aadsorasunclassified